ABBV

Pay Attention, Investors: Biosimilars Are on the Rise

The advent of biosimilars has already hurt Johnson & Johnson, but a bunch more pharma names will soon be in the line of fire. More 

Monday’s Vital Data: Bank of America Corp (BAC), Netflix, Inc. (NFLX) and AbbVie Inc (ABBV)

Bank of America (BAC) options traders prep for earnings, Netflix (NFLX) draws a bullish brokerage note, AbbVie’s (ABBV) Imbruvica was approved in the EU. More 

6 Pharmaceutical Stocks to Buy Now

This week, six pharmaceutical stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy"). More 

7 Pharmaceutical Stocks to Buy Now

The grades of seven pharmaceutical stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy"). More 

Biggest Movers in Healthcare Stocks Now – CBM VRX PRGO OPK

Healthcare stocks rose broadly on Wall Street so far on Wednesday, with the sector seeing an overall increase of 0.9%. More 

Biggest Movers in Healthcare Stocks Now – ACAD ABBV AMAG AMGN

Healthcare stocks finished down on Wall Street today, down 2.4%. More 

6 Pharmaceutical Stocks to Buy Now

This week, six pharmaceutical stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy"). More